Gregg Nyberg

Chief Technology Officer at Landmark Bio

Speaker

Gregg Nyberg is a biopharmaceutical executive with over twenty-five years of experience in process development, clinical manufacturing, technology transfer and commercialization. He is currently Chief Technology Officer at Artis Biosolutions, where he is responsible for process and analytical development, engineering, supply chain and clinical manufacturing for advanced therapies including cell and gene therapy. Prior to joining Artis, Gregg served in multiple leadership roles at Merck, Amgen and Wyeth BioPharma/Genetics Institute.